R
Rainer Riesenberg
Researcher at Ludwig Maximilian University of Munich
Publications - 63
Citations - 1543
Rainer Riesenberg is an academic researcher from Ludwig Maximilian University of Munich. The author has contributed to research in topics: Bone marrow & Spectrometer. The author has an hindex of 21, co-authored 63 publications receiving 1450 citations. Previous affiliations of Rainer Riesenberg include University of Graz & Analytik Jena.
Papers
More filters
Journal ArticleDOI
Expression of Indoleamine 2,3-Dioxygenase in Tumor Endothelial Cells Correlates with Long-term Survival of Patients with Renal Cell Carcinoma
Rainer Riesenberg,Christoph Weiler,Oliver Spring,Martin Eder,Alexander Buchner,Tanja Popp,Mirna Castro,Robert Kammerer,Osamu Takikawa,Rudolf Hatz,Christian G. Stief,Alfons Hofstetter,Wolfgang Zimmermann +12 more
TL;DR: IDO in endothelial cells might limit the influx of tryptophan from the blood to the tumor or generate tumor-toxic metabolites, thus restricting tumor growth and contributing to survival.
Journal ArticleDOI
Transcript signature predicts tissue NK cell content and defines renal cell carcinoma subgroups independent of TNM staging
Judith Eckl,Alexander Buchner,Petra U. Prinz,Rainer Riesenberg,Sabine Siegert,Robert Kammerer,Peter J. Nelson,Elfriede Noessner +7 more
TL;DR: The NK cell percentage within RCC-infiltrating lymphocytes, as determined by flow cytometry, allows ccRCC subgrouping in NKhigh/NKlow tissues independent of TNMG classification, and allows the analysis of large patient cohorts to substantiate a role of NK cells in cancer progression or response to immunotherapy.
Journal ArticleDOI
Lysis of Prostate Carcinoma Cells by Trifunctional Bispecific Antibodies (αEpCAM × αCD3)
TL;DR: The combination of double immunocytochemical and computerized video microscopic techniques may serve as an important improvement of validity of cell–cell interaction experiments using in vitro models.
Journal ArticleDOI
Immunocytochemical double staining of cytokeratin and prostate specific antigen in individual prostatic tumour cells
Rainer Riesenberg,R. Oberneder,M. Kriegmair,M. Epp,U. Bitzer,A. Hofstetter,Stephan Braun,Gert Riethmüller,Klaus Pantel +8 more
TL;DR: The approach presented appears to be a reliable method to phenotype individual prostatic carcinoma cells in patients with prostate cancer by use of monoclonal antibodies specific for cytokeratins.
Journal ArticleDOI
Isolation of circulating cancer cells from whole blood by immunomagnetic cell enrichment and unenriched immunocytochemistry in vitro.
TL;DR: Compared with unenriched immunocytochemistry immunomagnetic enrichment significantly improves the detection of epithelial cells added to blood, and a significant advantage was observed for positive selection.